International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 157-160 , March 2007

Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?

  • Dora Mbanya

      Affiliations

    • Department of Haematology, Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, BP 8046, Yaoundé, Cameroon
    • Corresponding Author InformationCorresponding author. Tel.: +237 231 52 35; fax: +237 231 40 39.
  • ,
  • Felix Assah

      Affiliations

    • Department of Public Health and Primary Care, University of Cambridge, UK
  • ,
  • Nicaise Ndembi

      Affiliations

    • Department of Haematology, Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, BP 8046, Yaoundé, Cameroon
  • ,
  • Lazare Kaptue

      Affiliations

    • Department of Haematology, Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, BP 8046, Yaoundé, Cameroon

Received 11 September 2005 ,Revised 18 January 2006 ,Accepted 1 February 2006.

References 

  1. UNAIDS/WHO: Global HIV/AIDS and STD surveillance. Report on the global HIV/AIDS epidemic. December 2004.
  2. Giorgi JV, Landay A. HIV Infection: Diagnosis and Disease Progression Evaluation. In:  Darzynkiewicz Z,  Robinson JP,  Crissman HA editor. Methods in cell biology. 42B:Orlando, FL: Academic Press; 1994;p. 437–455
  3. Beck EJ, Kupek EJ, Gompels EM, Pinching AJ. Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good enemy of the not so perfect. Int J STD AIDS. 1996;7:422–428
  4. Gupta S, Dingley SD, Evans BG. National CD4 surveillance in England and Wales: the utility of CD4 counts in monitoring a treatment effect at the population level in HIV-infected individuals. XIII International AIDS Conference, Durban, South Africa, 9–14 July, 2000. Abstract book, volume II, p. 383.
  5. Uppal SS, Gupta S, Verma S. Correlation of clinical and laboratory surrogate markers of immunodepletion with T cell subsets (CD4 & CD8) determined flow cytometrically in HIV infected patients: a hospital based study. J Commun Dis. 2003;35:140–153
  6. Centers for Disease Control and Prevention . 1993 revised classification system for HIV infection and expanded surveillance definition for AIDS among adolescents and adults. MMWR. 1992;41(RR-17):1–19
  7. Prince HE, Hirji K, Waldbeser LS, Plaeger-Marshall S, Kleinman S, Lanier LL. Influence of racial background on the distribution of T-cell subsets and Leu 11-positive lymphocytes in healthy blood donors. Diagn Immunol. 1985;3:33–37
  8. Easterbrook PJ, Farzadegan H, Hoover DR, Palenicek J, Chmiel JS, Kaslow RA, et al. Racial differences in rate of CD4 decline in HIV infected homosexual men. AIDS. 1996;10:1147–1155
  9. Sen R, Tewari AD, Sehgal PK, Singh U, Sikka R, Sen J. Clinico-haematological profile in acute and chronic Plasmodium falciparum malaria in children. J Commun Dis. 1994;26:31–38
  10. Reichert T, DeBruyere M, Deneys V, Totterman T, Lydyard P, Yuksel F, et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol. 1991;60:190–208
  11. Tugume SB, Piwowar EM, Lutalo T, Mugyenyi PN, Grant RM, Mangeni FW, et al. Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immun. 1995;2:233–235
  12. Zekeng L, Sadjo , Meli J, Kaptue L, Mpoudi NE, Hess R. T lymphocyte subset values among healthy Cameroonians. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:82–83
  13. Mbanya D, Zekeng L, Tapko J-B, Kamga L, Kaptue L. CD4+/CD8+ cell counts, CD4/CD8 ratio and clinical features in HIV seropositive patients in Yaounde, Cameroon. Proceedings of the 12th World AIDS Conference, Geneva, Switzerland, June 28–July 3, 1998. p. 17–20.
  14. Guarner J, Sanchez-Mejorada-Fernandez G, del Rio-Chiriboga C, Mohar A. Simplified CD4+ T lymphocyte count in patients with HIV/AIDS in Mexico. Salud Publica Mex. 1996;38:207–211
  15. Van der Ryst E, Kotze M, Joubert G, Steyn M, Pieters H, van der Westhuizen M, et al. Correlation among total lymphocyte count, absolute CD4+ count and CD4+ percentage in a group of HIV-1-infected South African patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:238–244
  16. World Health Organization . Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Geneva: HIV/AIDS Department; 2002;pp. 11–13
  17. Kamya MR, Semitala FC, Quinn TC, Ronald A, Njama-Meya D, Mayanja-Kizza H, et al. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda. Afr Health Sci. 2004;4:94–101
  18. Jadoon SM, Moin S, Ahmed TA, Bashir MM, Jadoon S. Smear-negative pulmonary tuberculosis and lymphocyte subsets. J Coll Physicians Surg Pak. 2004;14:419–422
  19. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho Martinez F. Sexually transmitted diseases in 1161 HIV-positive patients: a 38-month prospective study in southern Spain. J Eur Acad Dermatol Venereol. 1998;11:221–226
  20. Buchacz K, Patel P, Taylor M, Kerndt PR, Byers RH, Holmberg SD, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS. 2004;18:2075–2079
  21. Glencross D, Scott L, Aggett H, Sonday S, Scott CS. Microvolume fluorimetry for the determination of absolute CD4 and CD8 lymphocyte counts in patients with HIV: a comparative evaluation. Clin Lab Hematol. 1999;2:391–395

 Presented as “Correlation between total lymphocyte counts and CD4 counts in HIV-1 positive adults in Yaoundé”, XIV International AIDS Conference, Barcelona, Spain, July 7–12, 2002; Abstract No. MoPeB3099.

PII: S1201-9712(06)00064-6

doi: 10.1016/j.ijid.2006.02.008

International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 157-160 , March 2007